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Abstract
Background: Although bronchopulmonary dysplasia is closely associated with an arrest of alveolar development and 
pulmonary capillary dysplasia, it is unknown whether these two features are causally related. To investigate the 
relationship between pulmonary capillaries and alveolar formation, we partially embolized the pulmonary capillary 
bed.
Methods: Partial pulmonary embolization (PPE) was induced in chronically catheterized fetal sheep by injection of 
microspheres into the left pulmonary artery for 1 day (1d PPE; 115d gestational age; GA) or 5 days (5d PPE; 110-115d 
GA). Control fetuses received vehicle injections. Lung morphology, secondary septal crests, elastin, collagen, 
myofibroblast, PECAM1 and HIF1α abundance and localization were determined histologically. VEGF-A, Flk-1, PDGF-A 
and PDGF-Rα mRNA levels were measured using real-time PCR.
Results: At 130d GA (term ~147d), in embolized regions of the lung the percentage of lung occupied by tissue was 
increased from 29 ± 1% in controls to 35 ± 1% in 1d PPE and 44 ± 1% in 5d PPE fetuses (p < 0.001). Secondary septal 
crest density was reduced from 8 ± 0% in controls to 5 ± 0% in 1d PPE and 4 ± 0% in 5d PPE fetuses (p < 0.05), 
indicating impaired alveolar formation. The deposition of differentiated myofibroblasts (23 ± 1% vs 28 ± 1%; p < 0.001) 
and elastin fibres (3 ± 0% vs 4 ± 0%; p < 0.05) were also impaired in embolized lung regions of PPE fetuses compared to 
controls. PPE did not alter the deposition of collagen or PECAM1. At 116d GA in 5d PPE fetuses, markers of hypoxia 
indicated that a small and transient hypoxic event had occurred (hypoxia in 6.7 ± 1.4% of the tissue within embolized 
regions of 5d PPE fetuses at 116d compared to 0.8 ± 0.2% of tissue in control regions). There was no change in the 
proportion of tissue labelled with HIF1α. There was no change in mRNA levels of the angiogenic factors VEGF and Flk-1, 
although a small increase in PDGF-Rα expression at 116d GA, from 1.00 ± 0.12 in control fetuses to 1.61 ± 0.18 in 5d PPE 
fetuses may account for impaired differentiation of alveolar myofibroblasts and alveolar development.
Conclusions: PPE impairs alveolarization without adverse systemic effects and is a novel model for investigating the 
role of pulmonary capillaries and alveolar myofibroblasts in alveolar formation.
Introduction
Infants born very preterm often suffer from respiratory
failure at birth and require ventilatory support to survive.
However, mechanical ventilation can cause lung injury
and increases the risk of the infant developing bron-
chopulmonary dysplasia (BPD) [1]. One of the primary
pathological characteristics of BPD is the presence of
fewer alveoli that are larger and more simplified in struc-
ture, suggesting there has been an arrest of alveolar devel-
opment [1]. To improve the therapeutic options available
to these infants, it is critical to understand the factors that
regulate normal and abnormal development of alveoli.
In addition to reduced alveolar development, infants
with BPD also exhibit pulmonary capillary dysplasia [1]
and it is possible that these two features of BPD are
related. For instance, ligation of the pulmonary artery
(PA) [2,3] or ductus arteriosus (DA) [4] profoundly
impairs lung development, indicating that normal pulmo-
nary blood flow is essential for normal lung development.
Furthermore, inhibitors of angiogenesis and the disrup-
tion of genes involved in angiogenesis, vasculogenesis or
endothelial cell maturation, also impair alveolarization
[5-9]. However, those studies were complicated by either
widespread systemic effects on overall fetal development,
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or by reduced lung liquid production which can lead to
lung hypoplasia and impaired alveolar development [10].
Pulmonary hypertension is also common in very preterm
infants and impairs lung growth and alveolarization when
induced experimentally by prenatal ligation of the DA
[4,11,12]. However, it is unclear whether pulmonary
hypertension is a cause or consequence of altered pulmo-
nary vascular development in very preterm infants and
may be secondary to ventilation-induced microvascular
injury.
Inactivation of the vascular endothelial growth factor-A
(VEGF-A) gene in the respiratory epithelium of mice
blocks pulmonary capillary development and causes a
major defect in the formation of primary septa [13]. This
demonstrates that signalling between the respiratory epi-
thelium and pulmonary capillaries is important for pri-
mary septation. However, as these mice die within 1-2 h
of birth [13], before alveolar formation commences, the
relationship between alveolarization (secondary septa-
tion) and capillary development is unknown.
To study the interactions between the developing alve-
oli and pulmonary capillaries without inducing systemic
effects, we have injected microspheres into the left pul-
monary artery (LPA) of fetal sheep to disrupt the alveolar
capillary bed during the alveolar stage of development.
Our aim was to partially embolize the pulmonary vascu-
lar bed without causing chronic tissue hypoxia or necro-
sis. This study reports a new model of impaired alveolar
development that will be useful in studying the interac-
tions between the developing pulmonary vasculature and
alveoli.
Methods
Surgical Procedure
All experiments were performed on chronically catheter-
ized fetal sheep and were approved by the Monash Uni-
versity Committee for Ethics in Animal Experimentation.
Aseptic surgery was performed on pregnant Merino X
Border-Leicester ewes at 105-110 days gestational age
(GA; term ~147d GA). Anaesthesia of the ewe and fetus
was induced with thiopentane sodium (1 g) and main-
tained with 0.5-3% isoflurane in O2-N2O. Catheters were
inserted into the fetal carotid artery, jugular vein and
amniotic sac to monitor fetal well-being. Two catheters
were also inserted into the fetal trachea; one directed
toward the lungs and the other directed toward, but not
entering the larynx. After these catheters were external-
ized they were connected together to form a continuous
tracheal loop which allowed the normal flow of lung liq-
uid into and out of the fetal lung [14]. An ultrasonic flow
probe (4PSB, S series, Transonic Systems, USA) was
placed around the left pulmonary artery (LPA) to mea-
sure pulmonary blood flow (PBF) and a catheter was
inserted in the main pulmonary trunk and directed into
the LPA [15]. Catheters were externalized, all incisions
were closed and ewes and fetuses were allowed ~5 days
recovery before commencing experiments.
Experimental procedure
At the start of each experiment lung liquid was drained
(LLD) into a sterile bag to reduce fetal pulmonary vascu-
lar resistance and increase regional PBF [16,17] which
would improve the distribution of microspheres through-
out the lung and minimise their loss to the systemic cir-
culation. All fetuses received 1 ml injections into the LPA,
every 10 minutes, commencing 20 minutes following
LLD, of either vehicle (heparinized saline with 0.01%
Tween 80) or microspheres, followed with 3 ml of hepa-
rinized saline. Each microsphere injection contained
approximately 1 million, 15 μm, blue or violet micro-
spheres (EZ Trac Ultraspheres, Interactive Medical Tech-
nologies, Stason, USA) in heparinized saline with 0.01%
Tween 80. Following the injections, lung liquid was
returned to the lung.
Study 1
Fetal sheep were randomly allocated to one of three
groups. In each group, surgery was performed at ~105 or
~110 days, treatment (embolization or control) began at
110 or 115 days, and tissues were collected at 130 days of
gestation.
1. Control fetuses underwent surgery at ~110d GA.
At ~115d GA fetuses received 5-7 vehicle injections
(n = 6).
2. 1d PPE + 15d fetuses underwent surgery at ~110d
GA. At ~115d GA fetuses received 5-7 microsphere
injections (n = 6).
3. 5d PPE + 16d fetuses underwent surgery at ~105d
GA and received 5 microsphere injections per day for
5 days from ~110-115d GA (n = 5).
The PPE groups were administered 5-7 injections of
microspheres on each day of the embolization period
based on histological evidence demonstrating that this
level of embolization did not cause necrosis. PBF was
measured during embolization to measure the changes in
mean PBF caused by treatment. Our aim was to tran-
siently reduce PBF by ~25%, but in a preliminary experi-
ment, we found that injections of up to 23 million
microspheres only marginally reduced PBF.
Study 2
Fetal sheep were randomly allocated to one of two
groups:
1. Control fetuses, 117d GA. Lung tissue was col-
lected from fetuses that did not undergo surgery and
from fetuses that underwent surgery at ~105d GA
and received vehicle injections (n = 6 in total).
2. 5d PPE, 116d GA fetuses underwent surgery at
~105d GA and received 5 injections of microspheres
each day for 5 days from ~110-115d GA (n = 6). AtFilby et al. Respiratory Research 2010, 11:42
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116d GA, fetuses received an injection (i.v.) of pimo-
nidazole hydrochloride (Hypoxyprobe-1; 85-125 mg/
kg in saline; Natural Pharmacia International Inc.,
USA) 2 h prior to post-mortem, to determine regions
of tissue hypoxia.
Fetal body weight was estimated at surgery and the
actual dose of pimonidazole hydrochloride (Hypoxy-
probe-1) delivered was calculated using the post-mortem
body weight. Pimonidazole hydrochloride forms adducts
with proteins in hypoxic cells (PaO2 < 10 mmHg at 37°C)
[18] and these were detected later immunohistochemi-
cally.
Post-mortem and tissue collection
At the end of Study 1 (at ~130d GA) and Study 2 (at
~116d GA), ewes and fetuses were humanely killed by an
overdose of pentobarbitone sodium (6.5 g). Fetal body,
lungs, heart, liver and kidney weights were recorded. The
position of the LPA catheter and the location of visible
microspheres were noted. In Study 1 the whole lung was
fixed at 20 cmH2O via the airways with 4% paraformalde-
hyde. The kidneys and three cotyledons closest to the
point of entry of the umbilical vessels were collected to
analyse systemic microsphere distribution. Randomly
collected lung tissue sections were processed for light
microscopy and embedded in either paraffin or optimum
cutting tissue (OCT) compound. In Study 2 the lungs
were separated into the five lobes, weighed, cut into 1
cm3 portions, frozen in liquid nitrogen and stored at -
70°C.
Histological and immunohistochemical analysis
For all histological and immunohistochemical analyses,
three sections per fetus (two from the left upper and one
from the left lower lobe) were cut from paraffin-embed-
ded (5 μm), OCT-embedded (10 μm), or fresh frozen (10
μm) lung tissue. In a few fetuses, the PA catheter was
inadvertently placed into the right PA and in those fetuses
one section from each lobe (upper, middle, lower) of the
right lung was analyzed.
Histological stains and immunohistochemistry
Paraffin-embedded lung tissue sections from Study 1
were labeled with an antibody for α-smooth muscle actin
(αSMA), a marker of alveolar myofibroblasts, or stained
with; haematoxylin and eosin (H&E), Hart's stain for elas-
tin, or Gordon and Sweet's stain for reticulin which stains
collagen fibres I and III, as described previously [19,20].
Paraformaldehyde-fixed OCT-embedded lung sections
from Study 1 were labeled with an antibody for platelet
endothelial cell adhesion molecule 1 (PECAM1), a
marker of capillary endothelial cells; the OCT improved
detection of the PECAM1 antigen. In Study 2 fresh frozen
sections were labeled with antibodies against pimonida-
zole adducts (Hypoxyprobe-1) or HIF-1α (a marker of
hypoxia), or stained with H&E.
Paraffin sections were deparaffinized and rehydrated.
Paraffin and OCT-embedded lung tissue sections were
then immersed in 0.01 M Tris/0.001 M EDTA, pH 9 and
placed in a household microwave oven on high for 20 min
(αSMA) or 10 min (PECAM1) to improve antigen
retrieval. OCT and fresh frozen sections were air-dried at
room temperature before being immersed in water. Fresh
frozen sections were then post-fixed in ice-cold acetone
for 10 min. All sections were then washed in PBS (3 × 5
min), endogenous peroxidases were blocked and sections
were again washed in distilled water then PBS (2 × 5 min)
before non-specific binding was blocked. Sections were
incubated with primary antibody for 1-1.5 h at room tem-
perature or 24 h at 4°C (PECAM1). The primary antibod-
ies used were: monoclonal mouse anti-human αSMA
(1:200; Clone 1A4, DakoCytomation, Denmark), mono-
clonal mouse anti-ovine PECAM1 primary antibody
(1:75; Clone MCA 1097G, Serotek, UK), mouse anti-
Hypoxyprobe-1 primary antibody (1:10; Natural Pharma-
cia International Inc., USA) and rabbit polyclonal anti-
HIF-1α primary antibody (1:100; Novus Biologicals, Cat#
NB100-134, USA).
Following incubation with the primary antibody, sec-
tions were washed in PBS/0.1% Tween 20 (3 × 5 min)
before incubation with the secondary antibody (for HIF-
1α a biotinylated goat anti-rabbit IgG, Vector Laborato-
ries, USA was used; for all other primary antibodies a
biotinylated polyclonal goat anti-mouse IgG antibody was
used, DakoCytomation, Denmark). Sections were incu-
bated with secondary antibodies (1:500 for all except
HIF-1α 1:200) in DakoCytomation antibody diluent
(Dako, USA) for 1 h in a humidified chamber at room
t e m p e r a t u r e .  S e c t i o n s  w e r e  a g a i n  w a s h e d  i n  P B S / 0 . 1 %
Tween 20 (3 × 5 min), incubated in ABC reagent (diluted
1:150; Vectastain ABC detection, Vector Laboratories,
USA) and washed in PBS (3 × 5 min). The colour reaction
was developed by incubating the sections with 3,3'-
Diaminobenzidine (Sigma Fast DAB peroxides substrate,
Sigma, USA) for up to 7 min. Sections were washed in
PBS, counterstained with haematoxylin, dehydrated,
mounted and viewed under a light microscope.
Stereological and image analysis
Embolized lung tissue was initially visualized using a 20×
objective (field of view ~1.3 mm2). Preliminary observa-
tions indicated that there tended to be either very few
microspheres (i.e. 0-3) or a considerable number of
microspheres (~10-30) within these low power fields of
view, presumably reflecting regions of lung either being
poorly or well-perfused, respectively, at the times of
microsphere injection. Based on this observation, we
chose 10 microspheres as the lower cut-off for the defini-
tion of an embolized region. Once an embolized regionFilby et al. Respiratory Research 2010, 11:42
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had been visualized, the magnification was increased and
images were captured using a 100× objective. The saved
images were de-identified and the following analyses
were performed with the observer blinded to the group.
The percentage of lung occupied by tissue was calcu-
lated using image analysis of H&E stained lung tissue sec-
tions; for each field of view the total area of lung tissue
was expressed as a proportion of total area (tissue and
airspace). The density of secondary septal crests, a mea-
sure of alveolarization, was determined using sections
treated with Hart's stain for elastin to identify secondary
septal crests. A point counting method was used to count
the number of times the point grid fell on elastin-contain-
ing crests; this was expressed as a proportion of the num-
ber of times the point grid fell on lung parenchyma for
each field of view [21]. The relative abundance of elastin,
collagen, αSMA, PECAM1 and Hypoxyprobe-1 adducts
were determined by expressing the area of positively
stained lung tissue as a proportion of parenchymal tissue
area for each field of view. Positively stained lung tissue
was selected by colour segmentation of the images using
Image ProPlus (Media Cybernetics, USA). Differences in
nuclear HIF-1α staining were determined by expressing
the number of distal lung cells labelled with HIF-1α as a
proportion of the total number of nuclei present within a
field of view; a minimum of 3 fields of view and 1500
nuclei per animal were counted at 1000× magnification.
Lung tissue from the age-matched control fetuses were
used to control for all histological and immunohis-
tochemical analyses except for the Hypoxyprobe-1
adducts. In the latter, Hypoxyprobe-1 staining was com-
pared between non-embolized and embolized regions to
account for minor differences in dose between animals
caused by differences in body weight. Lung sections from
a fetus made chronically hypoxic by single umbilical
artery ligation (generously provided by V. Supramaniam,
Monash University) were used as a positive hypoxic tis-
sue control for the Hypoxyprobe-1 analysis.
Gene expression levels
Total RNA was extracted from 3-5 separate pieces of lung
tissue (~150 mg each) from each lobe and DNase treated
using a RNeasy Midi Kit and RNase-Free DNase Set,
(Qiagen, USA). To ensure that the RNA in PPE fetuses
came from embolized regions of the lung, the number of
microspheres per gram of tissue was determined for each
RNA extraction (see below). Only RNA from regions with
>30,000 microspheres/gram of lung tissue was selected
for qRT-PCR. RNA (500 ng) was then reverse transcribed
using random hexamers and M-MLV Reverse Tran-
scriptase (100U; Promega, USA). VEGF-A, its receptor
Flk-1, platelet derived growth factor (PDGF-A) and its
receptor PDGFR-α and 18S rRNA were amplified by qRT-
PCR using a Mastercycler® ep realplex real-time PCR sys-
tem (Eppendorf, Germany) (see Table 1 for primer
details). 18S rRNA was used to adjust for minor differ-
ences in the amount of cDNA template in each reaction.
Reactions containing 1 μl cDNA template (200 ng; 500 ng
for Flk-1), 2 μl primers (10 μM), 10 μl SYBR Green (Plati-
num® SYBR® Green qPCR SuperMix-UDG; Invitrogen Life
Technologies, USA) and 7 μl nuclease-free water were
performed in triplicate. A control reaction containing all
reagents except the cDNA template was included to
ensure there was no contaminating DNA. The mean
Table 1: Primers used for qRT-PCR
Gene of
interest
Accession #,
Species
Region amplified
(nt#)
Primers 5'-3'
F: Forward
R: Reverse
Annealing
temp.
(°C)
VEGF-A AF071015.1,
Ovis aries
264-338 F: CGAAAGTCTGGAGTGTGTGC
R: TATGTGCTGGCTTTGGTGAG
60
Flk-1 AF534634,
Ovis aries
385-462 F: CCCAATCAGAGACCCACG
R: GCCATCCTGTTGAGCGTTA
60
PDGF-A NM_001075231.1,
Bos taurus
784-856 F: ATGGCGTGTTACATTCCTA
R: TTCACGGAGGAGAACAAAGA
59
PDGF-Rα XM_590921,
Bos taurus
213-276 F: GCAGGAGATCAGAGTGGAGA
R: TGAAAGCTGGCAGAGGATTA
59
18S X01117,
Rattus norvegicus
1495-1673 F: GTCTGTGATGCCCTTAGATGTC
R: AAGCTTATGACCCGCACTTAC
59-60
nt# = nucleotide numbers, temp. = temperature.Filby et al. Respiratory Research 2010, 11:42
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threshold (CT) value for each sample was calculated and
subtracted from the mean CT value for 18S (ΔCT). The
ΔCT value was then normalized (2-ΔCT) and expressed rel-
ative to the mean mRNA levels of the gene of interest in
the control group.
Determination of systemic and pulmonary microsphere 
distribution
In Study 1, to determine the degree of embolization in tis-
s u e s  w i t h  b l ood  fl o w  i m m e d i a t e l y  d o wn - s t r e a m  o f  t h e
lung, the entire fetal kidneys and 3 cotyledons were
digested and microspheres counted. Tissues (~15 g/
digestion) were boiled in 15 ml of 2 M NaOH for 15 min
then vortexed, repeatedly, until the solution was homoge-
neous. Prewarmed (70°C) washing reagent (1% ethanol/
0.05% Triton X/0.1% Tween 80/0.02% sodium azide) was
added to a final volume of 50 ml, mixed, then centrifuged
(room temperature, 1500 rcf for 30 min) and the superna-
tant aspirated. In Study 2, pellets from RNA extractions
were also washed with washing reagent. All pellets were
then resuspended in 5 ml of 0.2% Tween 80/0.1% sodium
dodecyl benzene sulfonate/0.02% sodium azide, vortexed,
centrifuged for 15 min and the supernatant aspirated to a
final volume of 1-2 ml. Ten aliquots of the extracted
microsphere solution (0.9 μl each) were counted under a
light microscope using a haemocytometer. For each piece
of lung tissue used for RNA extraction in Study 2, this
value was used to identify embolized regions of the lung
(chosen as regions containing >30,000 microspheres/g
lung tissue) for gene expression analysis. For each piece of
kidney or cotyledon digested from Study 1, the aliquots
were used to determine the total number of microspheres
in each organ and to express that value as a proportion of
the total number of microspheres injected. This was used
to determine whether the effect of embolization was
largely limited to the lungs.
Statistical analysis
All data are expressed as mean ± standard error of the
mean (SEM). Statistical significance was achieved at a p-
value of <0.05. Differences in fetal body and organ
weights were determined using an ANOVA while differ-
ences in stereological measurements and immunohis-
tochemistry values were determined using a Nested
ANOVA. ANOVAs were followed by the post-hoc least
square difference (LSD) test. Gene expression levels were
analysed by a non-paired t-test.
Results
All fetuses were considered healthy throughout the
experiments as determined from arterial blood samples
(range pH 7.33-7.36, PaO2 18-25 mmHg, PaCO2 35-50
mmHg, SaO2 55-80%, tHb 7-11 g/dL). There were no sus-
tained alterations in mean PBF following embolization in
either study compared to the pre-embolisation period
(data not shown). There were no significant differences in
body weights, organ weights or lung volumes (T able 2)
between control and embolized fetuses in either study,
except that 1d PPE + 15d fetuses had smaller heart
weights corrected for body weight compared to control
fetuses. Very few of the total microspheres injected were
found in the fetal kidneys (0.44 ± 0.12% and 0.43 ±
0.23%), or in the three cotyledons closest to the point of
entry of the umbilical vessels (0.45 ± 0.16% and 0.90 ±
0.46%), in 1d PPE + 15d fetuses and 5d PPE + 16d fetuses,
respectively.
Morphology of the distal airways at 130d GA (Study 1)
Following embolization, the distal airways had thicker
lung parenchyma and fewer , simplified air sacs in com-
parison to age-matched controls (Figure 1A-C). However,
the areas of lung tissue affected by embolization were not
uniform throughout the entire lung. Embolized areas,
determined by the presence of ~10-30 microspheres in
low power fields of view, occurred in discrete regions and
occupied in total ~20% of the lung in 1d PPE + 15d
fetuses and ~30% of the lung in the 5d PPE + 15d fetuses.
These embolized regions had altered morphology, while
the intervening, non-embolized areas appeared unaf-
fected. In PPE fetuses therefore, although sections were
selected randomly, only embolized regions of the lung
were analysed and compared to lung tissue from control
fetuses, while non-embolized regions (containing <10
microspheres) were excluded from the analysis.
In control and embolized fetal lung tissue, no histologi-
cal signs of inflammation or necrosis were observed. In
contrast, a fetus that received 23 million microspheres
(over a 5 h period) as part of a pilot study, had evidence of
marked septal thickening and lung damage. This included
extravasation of erythrocytes and infiltration of inflam-
matory cells, particularly neutrophils and monocytes
(Figure 1D-E).
Percentage of lung occupied by tissue
The percentage of lung occupied by tissue at 130d GA in
embolized regions of lung, was significantly increased
from 28.6 ± 0.7% in control fetuses to 34.6 ± 0.9% in 1d
PPE + 15d fetuses (p < 0.001) and further increased to
44.1 ± 1.3% in 5d PPE + 16d fetuses (p < 0.001, Figure 1F).
Localization and relative abundance of elastin
In control fetuses, elastin staining in the peri-alveolar
lung parenchyma was primarily located in discrete bun-
dles at the tips of secondary septal crests, although thin
ribbon-like fibres were observed in some alveolar walls
(Figure 2A). Elastic fibres were not commonly located at
the base of the alveoli in control fetuses. In contrast,
embolized regions of the lung in PPE fetuses had stunted
secondary crests and elastic fibres were commonly
deposited throughout the primary septal wall and at theFilby et al. Respiratory Research 2010, 11:42
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base of alveoli (Figure 2B-C). The proportion of distal
lung tissue stained for elastin (relative abundance of elas-
tin) was significantly less in embolized regions of fetuses
exposed to 1d PPE + 15d (3.3 ± 0.2%) and 5d PPE + 16d
(3.2 ± 0.2%) compared with control fetuses (4.0 ± 0.3%, p
< 0.05, Figure 2G).
Secondary septal crest density
Light micrographs, stained for elastin were used to locate
secondary septal crests in control and embolized fetuses.
At 130d GA, the secondary septal crests in control fetuses
were in various stages of formation. Most were elongated,
mature secondary septal crests with large bundles of elas-
tin fibres present at the tips of the septa (Figures 2A
&2D). In 1d PPE + 15d and 5d PPE + 16d fetuses, the
morphology of secondary septal crests ranged from nor-
mal mature septal crests, to stunted in length or abnor-
mally shaped (Figures 2B-C &2E-F). Septal crest density
decreased from 7.8 ± 0.3% in control fetuses to 4.5 ± 0.2%
in embolized regions of 1d PPE + 15d fetuses (p < 0.001)
and to 3.6 ± 0.2% in 5d PPE + 16d fetuses (p < 0.05 rela-
tive to control and 1d PPE + 15d fetuses, Figure 2H).
Localization and relative abundance of collagen
Collagen staining was similar in the peri-alveolar paren-
chyma of control fetuses and embolized regions of PPE
fetuses; it was located within primary and secondary sep-
tal walls and at the tips of secondary septal crests (data
not shown). The proportion of distal lung tissue stained
for collagen fibres (relative abundance of collagen) was
similar in all groups: 16.9 ± 0.8% in control fetuses, 18.4 ±
0.9% in 1d PPE + 15d fetuses and 15.8 ± 0.8% in 5d PPE +
16d fetuses.
Alveolar myofibroblasts - localization and relative 
abundance of αSMA
Alveolar myofibroblasts in the peri-alveolar region of the
lung were detected using an antibody against αSMA. In
control fetuses, αSMA in the distal lung parenchyma was
primarily localized to secondary septal crests, although
some myofibroblasts were adjacent to the primary septal
wall (Figure 3A). In contrast, in embolized fetuses (Figure
3B-C), αSMA was located in stunted secondary septal
crests and to a greater degree in the primary septal wall.
The relative abundance of αSMA within the lung paren-
Table 2: Fetal body weights (kg), organ weights (g/kg) and lung volumes (cm3/kg) for fetuses in PPE treatment groups 
compared to corresponding age-matched control group (* p < 0.05). 
Study 1 Study 2
Age-matched 
control,
130d GA
1d PPE + 15d,
130d GA
5d PPE + 16d,
130d GA
Age-matched
control,
116d GA
5d PPE, 116d GA
Body wt
(kg)
3.4 ± 0.1 3.2 ± 0.3 3.5 ± 0.2 2.5 ± 0.4 2.3 ± 0.2
Wet lung wt/Body wt
(g/kg)
33.2 ± 1.7 33.8 ± 2.1 31.2 ± 2.8 39.4 ± 5.4 34.3 ± 3.6
Heart wt/Body wt
(g/kg)
7.4 ± 0.2 6.6 ± 0.1* 6.9 ± 0.3 6.3 ± 0.3 7.6 ± 0.2*
Liver wt/Body wt
(g/kg)
27.3 ± 1.4 24.5 ± 2.2 30.2 ± 2.3 27.9 ± 3.7 38.9 ± 2.3
Left Kidney wt/Body wt
(g/kg)
3.1 ± 0.1 2.9 ± 0.1 3.4 ± 0.1 3.7 ± 0.2 4.0 ± 0.2
Right Kidney wt/Body wt (g/kg) 3.1 ± 0.2 2.8 ± 0.2 3.3 ± 0.1 3.8 ± 0.2 3.9 ± 0.2
Total Lung Volume/Body wt (cm3/kg) 27.3 ± 1.7 29.2 ± 2.9 26.8 ± 3.0 N.D. N.D.
Left Lung Volume/Body wt (cm3/kg) 10.5 ± 0.7 10.4 ± 0.7 11.0 ± 1.1 N.D. N.D.
Right Lung Volume/Body wt (cm3/kg) 16.7 ± 1.0 18.8 ± 2.3 15.7 ± 2.0 N.D. N.D.
(ND = not determined)Filby et al. Respiratory Research 2010, 11:42
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Figure 1 Lung morphology and percentage tissue fraction of the lung for control and embolised fetuses. Light micrographs stained with hae-
matoxylin (purple: nuclei) and eosin (pink: cytoplasm) depicting lung morphology in control (A), 1d PPE + 15d (B), and 5d PPE +16d (C) lung tissue. 
Evidence of inflammatory cells and lung damage were only apparent in one fetus (D, E) which formed part of a pilot study and received significantly 
more microspheres than PPE fetuses. In that fetus, neutrophils (D, arrow), monocytes (E, thick arrows) and extravasation of erythrocytes (E, pointed 
arrowhead) could be seen. The scale bar in (C) represents 10 μm in all five images. The percentage tissue fraction of the lung (F) was greater in 1d PPE 
+ 15d than in control fetuses (* p < 0.001) and greater in 5d PPE + 16d fetuses than in 1d PPE + 15d or control fetuses (** p < 0.001).
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chyma was significantly lower in embolized regions of the
lung in 1d PPE + 15d fetuses (22.9 ± 1.0%) and 5d PPE +
16d fetuses (23.3 ± 0.9%) relative to control fetuses (27.8 ±
0.7%, p < 0.001, Figure 3D).
Pulmonary capillary development - localization and relative 
abundance of PECAM1
In control fetuses, light PECAM1 staining identified the
small capillaries in both the primary and secondary septal
walls (Figure 4A). In contrast, embolized regions of lung
from 1d PPE + 15d fetuses (Figure 4B) PECAM1 staining
was less common within the secondary septal walls.
Embolized regions of lung from 5d PPE + 16d fetuses
showed PECAM1 in the thickened primary septal walls
(Figure 4C). The relative abundance of PECAM1 in the
distal lung parenchyma was 6.9 ± 0.6% in control fetuses
which was similar to embolized regions of 1d PPE + 15d
(9.1 ± 1.6%) and 5d PPE + 16d (7.0 ± 0.7%) fetuses (Figure
4D).
Markers of hypoxia and vascular development at 116d GA 
(Study 2)
Changes in regional lung tissue hypoxia
The proportion of lung cells positively stained for HIF1α
was not different in embolized areas of lung in 5d PPE
fetuses at 116d GA (29.0 ± 11.4%) in comparison to con-
trol fetuses (27.9 ± 11.8%). There was also no evidence of
inflammatory cells in H&E stained lung tissue sections
from 5d PPE fetuses at 116d GA or in age-matched con-
trols.
Pimonidazole adducts were used as a sensitive method
of assessing whether the embolized regions were hypoxic.
Two fetuses were larger than expected at post-mortem so
the dose of pimonidazole hydrochloride administered (41
mg/kg and 73 mg/kg) was not sufficient for adduct detec-
tion. The remaining four fetuses received 106 ± 8.1 mg/
kg, which was sufficient for adduct detection. The pro-
portion of distal lung tissue stained for Hypoxyprobe-1
pimonidazole adducts (% hypoxic lung tissue) was very
low in control regions (0.8 ± 0.2%; Figure 5). Although
Hypoxyprobe-1 staining was significantly increased (p <
0.05) in embolized regions of the lung compared to con-
trol areas, only 6.7 ± 1.4% of embolized lung tissue had
d e t e c t a b l e  l ev e l s  o f  h ypo x i a.  I n  c o m p a r i s o n ,  i n  a  f e t u s
made chronically hypoxic (arterial PO2 of 14.3 mmHg)
due to single umbilical artery ligation, the percentage of
hypoxic lung tissue was 76.7 ± 4.7%.
mRNA levels of genes that regulate vascular and 
myofibroblast development
The mRNA levels of VEGF-A (1.02 ± 0.14 vs 1.00 ± 0.09),
the VEGF receptor Flk-1 (1.32 ± 0.22 vs 1.00 ± 0.14) and
PDGF-A  (0.86 ± 0.08 vs 1.00 ± 0.10) were similar at
116dGA in embolized lung regions of 5d PPE and control
fetuses, respectively (Figure 6). In contrast, the mRNA
levels of the PDGF receptor PDGF-Rα were significantly
increased in embolized regions of the lung in 5d PPE
fetuses (1.61 ± 0.18) compared to control fetuses (1.00 ±
0.12; p < 0.05; Figure 6) at 116d GA.
Discussion
The results of this study indicate that perturbations to
pulmonary capillary blood flow, induced by PPE impair
alveolar formation during the alveolar stage of lung devel-
opment. The effect of PPE on alveolar formation occurs
in the absence of significant embolization in other vascu-
lar beds and occurs without causing necrosis, significant
chronic lung tissue hypoxia or inflammation. The impair-
ment of alveolarization is, therefore, likely to result from
disrupted mesenchymal-epithelial signalling. The
observed increase in PDGF-Rα mRNA levels may play a
role in altered mesenchymal-epithelial signalling and
warrants further investigation. PPE is, therefore, a novel
experimental model that may allow elucidation of the
endothelial-epithelial interactions that regulate alveolar
development.
To study the interaction between developing capillaries
and alveoli, previous studies have used inhibitors of
angiogenesis [5,22,23] or transgenic alterations in angio-
genic mediators [6,24,25]. However, these treatments
caused significant systemic effects on multiple organ sys-
tems, thereby complicating the interpretation of the data.
Similarly, other models are complicated by one or more
of the following factors that in themselves could alter
alveolar development; reductions in fetal oxygenation
status, cessation of lung liquid production and impaired
lung growth (PA ligation) [2,3], pulmonary hypertension
(DA ligation) [4], or removal of the physicochemical envi-
ronment of the lung that is essential for normal lung
growth (lung allographs [26] and explants in culture [27]).
In contrast, the PPE model does not alter fetal oxygen-
ation, fetal growth or fetal lung growth and because the
ductus arteriosus remains open, PPE cannot induce pul-
monary hypertension. PPE therefore provides a model of
impaired alveolarization that is not confounded by other
changes in overall fetal or lung growth. With regard to
our results, it is of interest that a pulmonary epithelial
cell-specific VEGF-A null mouse has a major defect in the
formation of primary septa which becomes lethal after
birth [13]. However, as alveolar formation does not nor-
mally commence until days after birth in mice, the rela-
tionship between alveolarization (secondary septation)
and capillary development could not be tested in those
mice.
Development of the PPE model
PPE is a novel model of pulmonary embolization in fetal
sheep. We and others commonly use microspheres to
assess instantaneous blood flow to organs like the fetal
lung [16] and to embolize organs like the placenta [28],Filby et al. Respiratory Research 2010, 11:42
http://respiratory-research.com/content/11/1/42
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however, to our knowledge, this is the first model of fetal
lung embolization in vivo. To specifically target the pul-
monary capillary bed, we used small diameter micro-
spheres (15 μm) to block capillaries, but not arterioles; in
blocking the capillaries we did not affect mean pulmo-
nary blood flow or lung weights. A small reduction in
fetal heart weight was detected in the 1d PPE +15d group.
However, as there were very few microspheres in the vas-
cular beds immediately downstream of the lung, the
small reduction in heart weight is unlikely to be related to
Figure 2 Localization and relative abundance of elastin and density of secondary septal crests in control and embolised fetal lung tissue. 
Light micrographs depicting the localization of elastin (purple-black) staining in control (A), 1d PPE + 15d (B), and 5d PPE + 16d (C) lung tissue. Nuclei 
and cytoplasm are counterstained yellow. The arrows in A-C indicate secondary septal crests and the arrow-heads indicate deposition of elastin 
throughout the primary septal wall and around the base of alveoli in PPE fetuses (B-C). The scale bar in (C) represents 10 μm in images A-C and the 
scale bar in F represents 10 μm in images D-F. The relative abundance of elastin (G) was decreased in 1d PPE + 15d and 5d PPE + 16d fetuses relative 
to control fetuses (* p < 0.05). The density of secondary septal crests in the lung parenchyma (H) of 1d PPE + 15d fetuses was lower than in control 
fetuses (*p < 0.001) and lower in 5d PPE + 16d fetuses relative to 1d PPE + 15d fetuses and control fetuses (**p < 0.05).
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embolization. The long gestation length of fetal sheep
also gave us the opportunity to examine the effect of
embolization up to 2 weeks after treatment, allowing suf-
ficient time for the effect on alveolarization to fully mani-
fest. No evidence of necrosis or inflammation was
observed with embolization, except in one fetus that
received 23 million microspheres (over 5 h) during a pilot
study. Hence, capillary embolization impairs alveolariza-
tion without inducing tissue death, necrosis or overt
inflammation. The main limitation of the PPE model is
that the embolization is regional, which is likely due to
cyclical changes in regional pulmonary perfusion [29],
necessitating the identification of embolized regions.
Figure 3 Localization and relative abundance of αSMA in control and embolized fetal lung tissue. Light micrographs depicting the localization 
of αSMA (brown-black staining); a marker of myofibroblasts, in control (A), 1d PPE + 15d (B), and 5d PPE + 16d (C) lung tissue. Nuclei are counterstained 
blue with haematoxylin. The arrows show the presence of αSMA at the tips of secondary septal crests (A) and in the primary septal wall (B-C). The scale 
bar in (C) represents 10 μm in all three images. The relative abundance of αSMA (D) was less in 1d PPE + 15d and 5d PPE + 16d fetuses relative to 
control fetuses (* p < 0.001).
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PPE and alveolar development
PPE appears to significantly delay lung maturation as
indicated by an increase in lung parenchymal thickness,
reduced secondary septal crest formation as well as a
reduced and altered spatial pattern of elastin deposition.
This demonstrates that alveolarization was significantly
impaired by PPE and that the degree of impairment was
greater with increased duration of embolization. The spa-
tial pattern of elastin deposition was also found to be
altered, with more elastin fibres located around the pri-
mary septal walls following PPE. The percentage of lung
tissue stained for elastin was reduced in embolized areas,
Figure 4 Localization and relative abundance of PECAM1 in control and embolized fetal lung tissue. Light micrographs depicting the localiza-
tion of PECAM1 (brown staining); a marker of endothelial cells, in control (A), 1d PPE + 15d (B), and 5d PPE +16d (C) lung tissue. Nuclei are counter-
stained blue with haematoxylin. The thin arrow indicates normal pulmonary capillaries (A) and the thick arrows indicate abnormal capillary staining 
in the parenchyma of 1d PPE + 15d and 5d PPE +16d fetuses (B-C). The scale bar in (C) represents 10 μm in all three images. The relative abundance 
of PECAM1 (D) was not significantly different between groups. However, the PPE fetuses appeared to have larger capillaries compared to control fe-
tuses and PECAM1 staining was less common within the septal walls of PPE fetuses.
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however, this may have been due to an increase in paren-
chymal tissue volume rather than to a reduction in the
amount of elastin per se. Regardless, the alteration in the
site of elastin deposition, combined with an increase in
tissue and a reduction in the relative amount of elastin
per tissue area indicates that the biomechanical proper-
ties of the lung may also be impaired following PPE. A
similar pattern of elastin deposition occurs in the lungs of
preterm sheep following ventilation-induced lung injury
[19,21].
As alveolar myofibroblasts deposit elastin and other
ECM components within the secondary septa they play
an integral role in the development of the distal gas
exchange structures, particularly alveoli [30]. Alpha
smooth muscle actin (αSMA) is commonly used as a
marker of alveolar myofibroblasts and was reduced in 1d
PPE + 15d and 5d PPE + 16d fetuses. This suggests that
PPE reduced differentiation of peri-alveolar fibroblasts
into myofibroblasts. In addition, although alveolar myofi-
broblasts were generally found within the secondary
septa of control lung tissue, they were found dispersed
within the primary septal wall following PPE. We suggest
that PPE impaired alveolar myofibroblast differentiation
at the site of secondary septal crest formation, contribut-
ing to the altered spatial pattern of elastin deposition and
stunted growth of secondary septal crests. These results
are consistent with the suggestion that alveolar myofibro-
blasts are integral to signalling between the capillary
endothelium and the developing secondary septal crests
[30].
PPE and pulmonary vascular development
In embolized regions of the distal lung parenchyma, the
relative abundance of PECAM1 staining was not altered,
however, there appeared to be fewer capillaries located
within secondary septa. It is possible that that PPE
induced compensatory pulmonary capillary development
to sustain oxygen and nutrient delivery, but disrupted the
normal developmental pattern of alveolar capillary for-
mation. Further studies may elucidate this proposed cap-
Figure 5 Levels of Hypoxyprobe-1 pimonidazole adducts in lung tissue from 5d PPE fetuses. The levels of hypoxyprobe-1 pimonidazole ad-
ducts, a marker of hypoxic tissue (PaO2 <10 mmHG) was determined in embolized and non-embolized areas of lung tissue from 5d PPE fetuses († p 
< 0.05 relative to embolized and non-embolized regions of 5d PPE fetuses). As a comparison, the level of Hypoxyprobe-1 in a severely hypoxic fetus 
exposed to single umbilical artery ligation is shown (**p < 0.001).
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illary remodelling using scanned vascular casts. In a
previous study, complete ligation of the LPA induced
compensatory vascular growth in the lung from the sys-
temic circulation [31]; this must have occurred very rap-
idly to prevent complete necrosis of the left lung and
demonstrates the lung's rapid capacity for the formation
of a collateral blood supply. In our less severe PPE model,
it is possible that a collateral blood supply developed
from adjacent non-embolized small vessels rather than
from the systemic circulation. Indeed, microvascular
endothelial cells isolated from the lungs of young rats (10-
15 weeks old) have a much greater proliferative and vas-
culogenic potential than endothelial cells derived from
the pulmonary artery of the same animal [32]. Hence, the
capacity for vascular remodelling and growth is likely to
be much greater in the microvasculature, where embo-
lization occurred, than in the larger vessels. The altered
alveolar development in the current study is consistent
with lung pathologies seen in humans with alveolar capil-
lary dysplasia [33], persistent pulmonary hypertension of
the newborn [4,33] and disrupted alveolarization in
infants with BPD [34]. Infants with BPD have a reduction
in parenchymal capillaries and those present are often
enlarged and located distant to the air-tissue interface
[35].
Mechanisms by which PPE may impair alveolar 
development
The proportion of hypoxic tissue detected by Hypoxy-
probe-1 was increased in PPE fetuses, however this rep-
resented <7% of the embolized lung tissue. In
comparison, ~77% of lung tissue bound Hypoxyprobe-1
in the chronically hypoxemic fetus (PaO2 of 9-16 mmHg)
[36], suggesting that PPE induces very little tissue
hypoxia. The lack of an increase in nuclear HIF-1α and
the absence of inflammatory cell infiltration and necrosis
indicates that there was no or only a minor transient bio-
logical response to the tissue hypoxia detected in embo-
Figure 6 The mRNA levels of VEGF-A, Flk-1, PDGF-A and PDGF-Rα in control and 5d PPE fetuses. The mRNA levels of VEGF-A (A), Flk-1 (B), PDGF-
A (C) and PDGF-Rα (D) in 5d PPE and control fetuses corrected for the levels of the house-keeping gene 18S and expressed as fold change from the 
mean value in age-matched control fetuses. † p < 0.05.
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lized regions. Nevertheless, it may be sufficient to provide
a stimulus for revascularisation, which is a likely conse-
quence of PPE, as there was no overall reduction in capil-
lary density within the alveolar region at 130d GA. It is
possible that re-vascularisation was mediated by a tran-
sient increase in HIF-1α levels before tissue collection,
enabling activation of HIF-1α target genes such as VEGF-
A.
There is substantial evidence in support of a role for
VEGF-A and its receptor Flk-1 in mediating critical inter-
actions between the capillary endothelium and alveolar
epithelium [13,24,37-39]. As PPE physically disrupts
association of the capillaries (the site of Flk-1 expression)
with the epithelium (the site of VEGF-A  expression)
[37,40], we considered it likely that the VEGF:Flk-1 path-
way would be affected by PPE. The lack of change in
VEGF/Flk-1 expression was therefore surprising. How-
ever, it is possible that changes in VEGF mRNA levels in
the developing septa were masked by the high basal levels
of VEGF expression in vascular smooth muscle cells [41],
or that changes occurred prior to tissue collection, or that
VEGF/Flk-1 protein levels were elevated or released from
the ECM leading to receptor activation without detect-
able changes in gene expression.
PDGF-Rα mRNA levels were significantly increased by
5d PPE indicating that PDGF-A:PDGF-Rα signaling may
be altered. During saccular and alveolar development,
PDGF-A is predominately expressed by the lung epithe-
lium and PDGF-Rα  is expressed by alveolar myofibro-
blasts which deposit elastin at the tips of secondary septal
crests [30,42]. In PDGF-A null mice, myofibroblasts fail
to differentiate, alveolar elastin deposition is inhibited
and secondary septation is impaired [30,42]. Surprisingly,
over-expression of PDGF-A  in mouse lung epithelium
also leads to abnormal elastin deposition and to impaired
saccule development [43]. This suggests that PDGF-A
and its receptor may be a paracrine ligand:receptor pair
involved in myofibroblast differentiation, elastin deposi-
tion and alveolarization and that their expression levels
must be tightly regulated to enable correct development
of the lung's gas exchange regions. The mechanism by
which this occurs is not known. However, PDGF-B and
PDGF-Rβ cause recruitment of pericytes (smooth muscle
cells) to developing blood vessels [44,45] and mesangial
cells to glomeruli [46,47]. Hence it is possible that in the
lung, epithelial derived PDGF-A may recruit PDGF-Rα
positive alveolar myofibroblasts to the site of secondary
septation. Clearly, these results indicate that further
investigation of PDGF-A:PDGF-Rα protein levels and its
downstream signaling pathway within alveolar myofibro-
blasts during alveolarization is warranted.
Conclusions
The results of this study demonstrate that PPE disrupts
alveolarization. PPE specifically targets disruption of the
pulmonary capillary bed and impairs alveolarization
without reducing PBF or inducing sustained hypoxia,
inflammation or necrosis. It is also possible that PPE dis-
rupted signalling between the capillary endothelium, the
alveolar myofibroblasts and the pulmonary epithelium
via changes in the PDGF-A/PDGF-Rα pathway. Future
application of the PPE model will be useful in investigat-
ing the interactions between the developing capillaries
and the alveoli. Such studies may increase our under-
standing of the pathogenesis of BPD, and improve the
therapeutic options available for infants with BPD.
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